10 Adverse events 5% in SUSTAIN 5 8,10 AEs occurring in 5% of participants treated with Ozempic in SUSTAIN 5 Incidence of severe hypoglycemia was 1.5% across all placebo-controlled trials 1 Incidence of severe hypoglycemia or blood glucose-confirmed hypoglycemia (% of patients) was 8,10 : 8.3% with Ozempic 0.5 mg + basal insulin MET 10.7% with Ozempic 1 mg + basal insulin MET 5.3% with placebo + basal insulin MET Patients receiving Ozempic in combination with an insulin secretagogue (eg, sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia 1 ADA=American Diabetes Association
This is exactly why we titrate slowly, monitor your response, and keep your full medication list in view rather than prescribing once and walking away
Theoretically, this could affect how oral medications are absorbed
Laxatives can provide relief from constipation, but they also come with potential risks, especially if used too often
Long-Term Weight Management After Semaglutide Will I Regain Weight After Stopping Semaglutide
Coverage policies change frequently
